Cargando…
Cancer Stem Cells in Soft-Tissue Sarcomas
Soft tissue sarcomas (STS) are a rare group of mesenchymal solid tumors with heterogeneous genetic profiles and clinical features. Systemic chemotherapy is the backbone treatment for advanced STS; however, STS frequently acquire resistance to standard therapies, which highlights the need to improve...
Autores principales: | Martínez-Delgado, Paula, Lacerenza, Serena, Obrador-Hevia, Antonia, Lopez-Alvarez, Maria, Mondaza-Hernandez, José L., Blanco-Alcaina, Elena, Sanchez-Bustos, Paloma, Hindi, Nadia, S. Moura, David, Martin-Broto, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349510/ https://www.ncbi.nlm.nih.gov/pubmed/32532153 http://dx.doi.org/10.3390/cells9061449 |
Ejemplares similares
-
CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
por: Moura, David S., et al.
Publicado: (2020) -
Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas
por: López-Álvarez, María, et al.
Publicado: (2022) -
WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
por: Martinez-Font, Esther, et al.
Publicado: (2021) -
ISG15 as a prognostic biomarker in solitary fibrous tumour
por: Mondaza-Hernandez, Jose L., et al.
Publicado: (2022) -
A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons
por: Martin-Broto, Javier, et al.
Publicado: (2021)